InsidersTradesSigma
Track the Pharmanutra PR - First Sales on the US Market share price and the full management transaction log of the company, a listed equity based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra PR - First Sales on the US Market has published 1 reports. Market capitalisation: €804.3m. The latest transaction was disclosed on 3 October 2023 (Other). The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Pharmanutra PR ha realizado sus primeras ventas en el mercado estadounidense, lo que marca un hito importante en su expansión internacional. La empresa se especializa en el desarrollo de productos farmacéuticos innovadores.